Natco Pharma, 524816, NATCOPHARM Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

14,724.62
9.46
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

12,287.22
0.73%
1.68

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

14.52
16.64
17.84

EBITDA CAGR (%)

10 Years
5 Years
3 Years

23.19
29.44
19.20

PAT CAGR (%)

10 Years
5 Years
3 Years

28.21
33.73
38.14

P:E (Median)

8 Years
5 Years
3 Years

19.48
18.55
13.42

P:BV (Average)

8 Years
5 Years
3 Years

3.24
3.00
2.73

EV:EBITDA (Average)

8 Years
5 Years
3 Years

15.74
15.98
9.57

Earnings Forecasts:

(Updated: 14-02-2026)

Description 2024 2025 2026 2027
Adj EPS 105.26 69.56 37.24 44.06
P/E Ratio 7.83 11.84 22.12 18.70
Revenue 4429.5 3961.11 2881.44 3298.71
EBITDA 2196 1440.82 654.74 780.09
Net Income 1885.4 1263.77 626.85 767.31
ROA 24.27 5.08 5.69
P/B Ratio 1.94 1.69 1.59 1.53
ROE 28.01 15.71 7.59 8.39
FCFF 1428 981.52 760.84 1097.49
FCFF Yield 10.96 7.53 5.84 8.43
Net Debt -2217.4 -2435.5 -3410.9
BVPS 424.71 486.79 517.6 540.17

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 528.80 407.60 29.74% 1,264.30 1,292.60 -2.19% 1,192.70 1,236.90 -3.57% 1,157.40 964.80 19.96%
Expenses 408.50 378.20 8.01% 711.80 501.90 41.82% 653.00 473.90 37.79% 596.20 512.10 16.42%
EBITDA 120.30 29.40 309.18% 552.50 790.70 -30.13% 539.70 763.00 -29.27% 561.20 452.70 23.97%
EBIDTM 22.75% 7.21% 43.70% 61.17% 45.25% 61.69% 48.49% 46.92%
Other Income 55.30 168.00 -67.08% 93.30 51.40 81.52% 59.60 39.80 49.75% 62.10 35.90 72.98%
Interest 8.30 3.40 144.12% 11.70 3.00 290.00% 2.60 4.40 -40.91% 8.80 4.50 95.56%
Depreciation 42.10 43.70 -3.66% 48.10 42.20 13.98% 53.80 40.40 33.17% 93.70 51.60 81.59%
PBT 125.20 150.30 -16.70% 586.00 796.90 -26.47% 542.90 758.00 -28.38% 520.80 432.50 20.42%
Tax 18.30 25.40 -27.95% 85.10 135.80 -37.33% 78.80 121.70 -35.25% 92.70 83.40 11.15%
PAT 106.90 124.90 -14.41% 500.90 661.10 -24.23% 464.10 636.30 -27.06% 428.10 349.10 22.63%
PATM 20.22% 30.64% 39.62% 51.15% 38.91% 51.44% 36.99% 36.18%
EPS 5.97 6.97 -14.35% 27.97 36.91 -24.22% 25.91 35.53 -27.08% 23.90 19.49 22.63%

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 647.30 474.80 36.33% 1,363.00 1,371.10 -0.59% 1,328.90 1,362.60 -2.47% 1,221.00 1,068.30 14.29%
Expenses 488.60 436.00 12.06% 783.80 566.80 38.29% 757.90 557.80 35.87% 672.90 571.00 17.85%
EBITDA 158.70 38.80 309.02% 579.20 804.30 -27.99% 571.00 804.80 -29.05% 548.10 497.30 10.22%
EBIDTM 24.52% 8.17% 42.49% 58.66% 42.97% 59.06% 44.89% 46.55%
Other Income 58.10 176.30 -67.04% 100.00 63.80 56.74% 61.70 48.10 28.27% 66.30 42.00 57.86%
Interest 9.50 4.40 115.91% 13.10 4.10 219.51% 3.20 5.20 -38.46% 10.20 6.20 64.52%
Depreciation 46.20 47.00 -1.70% 52.40 45.80 14.41% 57.60 44.10 30.61% 98.30 55.50 77.12%
PBT 161.10 163.70 -1.59% 613.70 818.20 -24.99% 571.90 803.60 -28.83% 505.90 477.60 5.93%
Tax 20.70 31.30 -33.87% 95.80 141.70 -32.39% 91.60 135.10 -32.20% 99.90 91.30 9.42%
PAT 140.40 132.40 6.04% 517.90 676.50 -23.44% 480.30 668.50 -28.15% 406.00 386.30 5.10%
PATM 21.69% 27.89% 38.00% 49.34% 36.14% 49.06% 33.25% 36.16%
EPS 8.46 7.43 13.86% 28.96 37.84 -23.47% 26.85 37.35 -28.11% 22.72 21.58 5.28%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 4,143.20 4,094.50 3,568.90 2,351.00 1,767.80 1,653.50 1,790.20 1,986.30 2,091.30 1,958.00 1,021.40 Net Sales Growth 6.18% 14.73% 51.80% 32.99% 6.91% -7.64% -9.87% -5.02% 6.81% 91.70% Cost Of Goods Sold 671.50 545.00 525.80 485.60 502.10 472.30 369.80 317.60 388.50 572.80 256.30 Gross Profit 3,471.70 3,549.50 3,043.10 1,865.40 1,265.70 1,181.20 1,420.40 1,668.70 1,702.80 1,385.20 765.10 GP Margin 83.79% 86.69% 85.27% 79.34% 71.60% 71.44% 79.34% 84.01% 81.42% 70.75% 74.91% Total Expenditure 2,369.50 1,952.40 1,931.90 1,530.20 1,554.80 1,238.30 1,212.20 1,169.80 1,162.90 1,266.00 740.70 Power & Fuel Cost - 93.10 88.90 81.90 76.40 59.40 62.40 59.60 56.10 50.50 43.70 % Of Sales - 2.27% 2.49% 3.48% 4.32% 3.59% 3.49% 3.00% 2.68% 2.58% 4.28% Employee Cost - 515.30 454.90 425.70 410.10 380.00 356.10 340.20 312.20 232.10 171.90 % Of Sales - 12.59% 12.75% 18.11% 23.20% 22.98% 19.89% 17.13% 14.93% 11.85% 16.83% Manufacturing Exp. - 357.70 341.70 269.90 340.80 160.50 230.40 257.50 175.10 134.20 100.60 % Of Sales - 8.74% 9.57% 11.48% 19.28% 9.71% 12.87% 12.96% 8.37% 6.85% 9.85% General & Admin Exp. - 246.80 253.10 155.70 122.50 92.60 111.20 103.90 96.00 78.30 56.90 % Of Sales - 6.03% 7.09% 6.62% 6.93% 5.60% 6.21% 5.23% 4.59% 4.00% 5.57% Selling & Distn. Exp. - 105.60 117.40 59.50 27.00 29.20 22.60 33.50 98.00 128.80 88.40 % Of Sales - 2.58% 3.29% 2.53% 1.53% 1.77% 1.26% 1.69% 4.69% 6.58% 8.65% Miscellaneous Exp. - 88.90 150.10 51.90 75.90 44.30 59.70 57.50 37.00 69.30 88.40 % Of Sales - 2.17% 4.21% 2.21% 4.29% 2.68% 3.33% 2.89% 1.77% 3.54% 2.24% EBITDA 1,773.70 2,142.10 1,637.00 820.80 213.00 415.20 578.00 816.50 928.40 692.00 280.70 EBITDA Margin 42.81% 52.32% 45.87% 34.91% 12.05% 25.11% 32.29% 41.11% 44.39% 35.34% 27.48% Other Income 270.30 323.50 104.70 109.40 94.60 103.50 123.80 129.80 39.40 13.20 12.90 Interest 31.40 19.60 14.50 8.60 13.30 11.30 20.60 18.80 14.70 17.50 21.90 Depreciation 237.70 220.00 171.90 150.90 138.40 115.20 98.10 80.10 65.50 53.60 50.20 PBT 1,774.90 2,226.00 1,555.30 770.70 155.90 392.20 583.10 847.40 887.60 634.10 221.50 Tax 274.90 375.60 248.70 133.60 16.80 82.70 108.60 180.30 189.40 139.30 45.00 Tax Rate 15.49% 16.87% 15.99% 17.33% 10.78% 21.09% 18.62% 21.28% 21.34% 21.97% 20.32% PAT 1,500.00 1,850.40 1,306.60 637.10 139.10 309.50 474.50 667.10 698.20 494.80 176.50 PAT before Minority Interest 1,500.00 1,850.40 1,306.60 637.10 139.10 309.50 474.50 667.10 698.20 494.80 176.50 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 36.20% 45.19% 36.61% 27.10% 7.87% 18.72% 26.51% 33.59% 33.39% 25.27% 17.28% PAT Growth -15.32% 41.62% 105.09% 358.02% -55.06% -34.77% -28.87% -4.45% 41.11% 180.34% EPS 83.75 103.32 72.95 35.57 7.77 17.28 26.49 37.25 38.98 27.63 9.85

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 4,560.20 4,429.50 3,998.80 2,707.10 1,944.80 2,052.10 1,915.00 2,094.50 2,184.80 2,020.20 1,141.30 Net Sales Growth 6.63% 10.77% 47.72% 39.20% -5.23% 7.16% -8.57% -4.13% 8.15% 77.01% Cost Of Goods Sold 785.00 641.50 667.90 583.20 528.40 483.70 354.40 332.70 411.10 599.10 341.10 Gross Profit 3,775.20 3,788.00 3,330.90 2,123.90 1,416.40 1,568.40 1,560.60 1,761.80 1,773.70 1,421.10 800.20 GP Margin 82.79% 85.52% 83.30% 78.46% 72.83% 76.43% 81.49% 84.12% 81.18% 70.34% 70.11% Total Expenditure 2,703.20 2,235.70 2,247.40 1,795.40 1,681.30 1,448.30 1,332.40 1,299.70 1,256.40 1,336.80 868.70 Power & Fuel Cost - 93.10 88.90 81.90 76.40 61.10 62.40 59.60 56.20 50.50 43.70 % Of Sales - 2.10% 2.22% 3.03% 3.93% 2.98% 3.26% 2.85% 2.57% 2.50% 3.83% Employee Cost - 594.50 525.00 486.70 444.80 414.90 375.00 355.90 325.60 243.20 189.60 % Of Sales - 13.42% 13.13% 17.98% 22.87% 20.22% 19.58% 16.99% 14.90% 12.04% 16.61% Manufacturing Exp. - 374.80 368.40 279.60 353.60 165.70 243.30 276.40 182.60 141.20 105.20 % Of Sales - 8.46% 9.21% 10.33% 18.18% 8.07% 12.70% 13.20% 8.36% 6.99% 9.22% General & Admin Exp. - 304.00 313.00 208.80 152.80 242.90 132.60 126.40 105.50 88.10 73.40 % Of Sales - 6.86% 7.83% 7.71% 7.86% 11.84% 6.92% 6.03% 4.83% 4.36% 6.43% Selling & Distn. Exp. - 136.40 153.00 96.10 43.70 34.40 98.10 90.00 136.90 143.20 91.60 % Of Sales - 3.08% 3.83% 3.55% 2.25% 1.68% 5.12% 4.30% 6.27% 7.09% 8.03% Miscellaneous Exp. - 91.40 131.20 59.10 81.60 45.60 66.60 58.70 38.50 71.50 91.60 % Of Sales - 2.06% 3.28% 2.18% 4.20% 2.22% 3.48% 2.80% 1.76% 3.54% 2.11% EBITDA 1,857.00 2,193.80 1,751.40 911.70 263.50 603.80 582.60 794.80 928.40 683.40 272.60 EBITDA Margin 40.72% 49.53% 43.80% 33.68% 13.55% 29.42% 30.42% 37.95% 42.49% 33.83% 23.89% Other Income 286.10 356.70 128.10 128.50 99.00 106.00 107.40 130.20 40.40 13.90 9.90 Interest 36.00 23.90 19.20 14.50 17.70 13.30 21.50 19.30 15.40 18.50 22.90 Depreciation 254.50 235.20 186.80 163.80 142.60 116.90 99.80 81.00 66.20 54.40 51.00 PBT 1,852.60 2,291.40 1,673.50 861.90 202.20 579.60 568.70 824.70 887.20 624.40 208.60 Tax 308.00 408.00 285.20 146.60 32.20 137.20 110.60 182.30 192.00 139.50 52.80 Tax Rate 16.63% 17.81% 17.04% 17.01% 15.92% 23.67% 19.45% 22.11% 21.64% 22.34% 25.31% PAT 1,544.60 1,885.40 1,388.30 715.30 170.00 440.90 460.80 644.40 696.20 486.00 157.10 PAT before Minority Interest 1,546.30 1,883.40 1,388.30 715.30 170.00 442.40 458.10 642.40 695.20 484.90 155.80 Minority Interest 1.70 2.00 0.00 0.00 0.00 -1.50 2.70 2.00 1.00 1.10 1.30 PAT Margin 33.87% 42.56% 34.72% 26.42% 8.74% 21.49% 24.06% 30.77% 31.87% 24.06% 13.77% PAT Growth -17.12% 35.81% 94.09% 320.76% -61.44% -4.32% -28.49% -7.44% 43.25% 209.36% EPS 86.24 105.27 77.52 39.94 9.49 24.62 25.73 35.98 38.87 27.14 8.77

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 7,333.90 5,592.30 4,702.00 4,191.90 4,091.10 3,869.50 3,563.20 3,125.40 1,699.70 1,336.30 Share Capital 35.80 35.80 36.50 36.50 36.50 36.40 36.50 36.90 34.90 34.80 Total Reserves 7,298.10 5,556.50 4,665.50 4,152.00 4,037.00 3,809.50 3,495.80 3,064.30 1,649.40 1,291.80 Non-Current Liabilities 30.40 69.00 116.90 134.90 142.90 117.50 83.10 47.00 37.70 27.90 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.90 0.00 0.00 0.00 0.00 Long Term Provisions 65.60 70.90 85.30 95.70 99.60 90.20 71.00 32.40 21.90 12.50 Current Liabilities 864.60 885.60 569.00 651.20 518.50 659.70 709.80 563.80 609.70 478.50 Trade Payables 225.10 183.30 182.40 141.20 139.50 234.20 201.80 245.40 251.40 270.10 Other Current Liabilities 210.70 204.70 201.40 104.00 111.10 93.40 108.50 131.70 122.80 110.90 Short Term Borrowings 273.10 363.20 159.90 389.00 255.10 313.10 384.50 173.00 220.60 96.00 Short Term Provisions 155.70 134.40 25.30 17.00 12.80 19.00 15.00 13.70 14.90 1.50 Total Liabilities 8,228.90 6,546.90 5,387.90 4,978.00 4,752.50 4,646.70 4,356.10 3,736.20 2,347.10 1,842.70 Net Block 2,516.80 2,286.70 2,233.80 2,174.20 2,005.90 1,574.50 1,214.90 1,015.30 829.00 705.60 Gross Block 3,783.70 3,359.50 3,157.10 2,977.80 2,678.30 2,133.70 1,678.20 1,399.60 1,151.00 975.90 Accumulated Depreciation 1,216.90 1,072.80 923.30 803.60 672.40 559.20 463.30 384.30 322.00 270.30 Non Current Assets 3,540.90 3,136.50 2,893.20 2,810.30 2,584.00 2,406.80 2,088.70 1,682.00 1,312.00 1,051.80 Capital Work in Progress 225.30 133.90 62.80 128.70 223.40 517.80 637.50 480.00 336.20 211.90 Non Current Investment 565.10 577.80 517.60 430.40 294.90 186.10 117.60 101.30 85.90 71.70 Long Term Loans & Adv. 73.00 111.50 78.80 72.40 55.60 124.30 110.40 83.10 60.40 62.00 Other Non Current Assets 160.70 26.60 0.20 4.60 4.20 4.10 8.30 2.30 0.50 0.60 Current Assets 4,688.00 3,410.40 2,494.70 2,167.70 2,168.50 2,239.90 2,267.40 2,054.20 1,035.10 790.90 Current Investments 290.00 163.90 139.90 119.60 42.10 5.00 126.80 48.30 8.90 22.10 Inventories 642.10 596.90 616.00 697.70 769.20 524.40 508.40 425.80 336.90 351.90 Sundry Debtors 1,178.20 1,076.60 793.10 575.60 399.80 536.70 491.60 606.00 468.90 255.80 Cash & Bank 1,856.90 864.90 412.00 100.90 262.80 54.10 262.70 172.10 25.10 40.20 Other Current Assets 720.80 86.10 57.60 78.10 694.60 1,119.70 877.90 802.00 195.30 120.90 Short Term Loans & Adv. 597.40 622.00 476.10 595.80 599.40 1,025.90 769.50 748.80 169.60 95.50 Net Current Assets 3,823.40 2,524.80 1,925.70 1,516.50 1,650.00 1,580.20 1,557.60 1,490.40 425.40 312.40 Total Assets 8,228.90 6,546.90 5,387.90 4,978.00 4,752.50 4,646.70 4,356.10 3,736.20 2,347.10 1,842.70

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 7,607.00 5,853.10 4,873.80 4,263.60 4,121.60 3,773.50 3,489.00 3,072.20 1,649.30 1,295.70 Share Capital 35.80 35.80 36.50 36.50 36.50 36.40 36.50 36.90 34.90 34.80 Total Reserves 7,571.20 5,817.30 4,837.30 4,223.70 4,067.60 3,713.60 3,421.70 3,011.40 1,599.00 1,251.20 Non-Current Liabilities 24.90 61.00 100.50 135.10 142.90 117.80 83.40 47.10 37.70 28.00 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.90 0.00 0.00 0.00 0.00 Long Term Provisions 65.60 70.90 85.30 95.70 99.60 90.20 71.00 32.40 21.90 12.50 Current Liabilities 943.50 972.80 683.10 710.40 525.60 685.30 728.70 592.00 626.50 493.10 Trade Payables 274.90 235.50 263.80 161.80 146.20 255.40 217.00 269.10 262.70 275.60 Other Current Liabilities 238.60 238.90 227.30 126.70 99.50 95.90 109.80 133.40 127.10 114.20 Short Term Borrowings 273.10 363.20 165.00 404.00 265.80 315.00 386.30 173.20 221.60 98.40 Short Term Provisions 156.90 135.20 27.00 17.90 14.10 19.00 15.60 16.30 15.10 4.90 Total Liabilities 8,580.70 6,886.90 5,657.40 5,109.10 4,791.90 4,587.80 4,303.10 3,715.10 2,317.60 1,821.70 Net Block 2,698.00 2,490.80 2,426.90 2,311.80 2,023.20 1,584.40 1,227.20 1,018.60 833.00 710.10 Gross Block 4,015.20 3,603.20 3,375.10 3,126.90 2,702.10 2,148.70 1,694.50 1,407.60 1,158.70 983.30 Accumulated Depreciation 1,267.20 1,112.40 948.20 815.10 678.90 564.30 467.30 389.00 325.70 273.20 Non Current Assets 3,310.70 2,863.40 2,657.10 2,622.40 2,447.10 2,262.20 1,955.90 1,584.40 1,230.30 984.70 Capital Work in Progress 225.40 137.30 64.30 129.50 223.40 518.00 637.60 480.00 336.30 211.80 Non Current Investment 152.80 95.90 87.30 104.40 151.90 83.60 19.90 8.10 0.10 0.10 Long Term Loans & Adv. 73.80 112.70 78.30 72.00 44.30 72.00 62.80 75.40 60.40 62.10 Other Non Current Assets 160.70 26.70 0.30 4.70 4.30 4.20 8.40 2.30 0.50 0.60 Current Assets 5,270.00 4,023.50 3,000.30 2,486.70 2,344.80 2,325.60 2,347.20 2,130.70 1,087.30 837.00 Current Investments 320.80 443.50 305.00 203.70 151.80 28.70 148.70 68.40 32.10 22.10 Inventories 765.80 700.50 742.90 762.00 798.20 558.00 529.00 438.40 348.90 357.30 Sundry Debtors 1,246.60 1,188.90 856.10 620.60 412.90 551.30 506.20 637.50 475.20 261.60 Cash & Bank 2,176.00 952.90 546.30 206.10 283.50 66.00 279.50 183.70 35.80 45.20 Other Current Assets 760.80 99.50 64.40 88.10 698.40 1,121.60 883.80 802.70 195.30 150.80 Short Term Loans & Adv. 625.70 638.20 485.60 606.20 603.70 1,030.00 776.40 749.50 169.50 125.40 Net Current Assets 4,326.50 3,050.70 2,317.20 1,776.30 1,819.20 1,640.30 1,618.50 1,538.70 460.80 343.90 Total Assets 8,580.70 6,886.90 5,657.40 5,109.10 4,791.90 4,587.80 4,303.10 3,715.10 2,317.60 1,821.70

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 1,662.00 1,196.40 784.40 57.70 183.50 422.50 698.80 476.40 329.80 189.90 PBT 2,226.00 1,555.30 770.70 155.90 392.20 583.10 847.40 887.60 634.10 221.50 Adjustment -20.40 150.90 85.40 118.50 58.40 45.20 12.10 74.40 99.80 81.70 Changes in Working Capital -199.00 -257.80 76.70 -184.20 -190.20 -100.70 14.20 -281.20 -281.70 -68.50 Cash after chg. in Working capital 2,006.60 1,448.40 932.80 90.20 260.40 527.60 873.70 680.80 452.20 234.70 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -344.60 -252.00 -148.40 -32.50 -76.90 -105.10 -174.90 -204.40 -122.40 -44.80 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -1,443.90 -960.50 -436.60 -92.50 -3.20 -165.00 -645.20 -1,131.10 -290.60 -249.30 Net Fixed Assets -515.60 -273.50 -113.40 -204.80 -250.20 -335.80 -436.10 -392.40 -299.40 -303.91 Net Investments -113.40 -84.20 -107.50 -213.00 -145.90 53.30 -94.80 -54.80 -1.00 37.47 Others -814.90 -602.80 -215.70 325.30 392.90 117.50 -114.30 -683.90 9.80 17.14 Cash from Financing Activity -212.40 -237.30 -346.80 35.60 -183.10 -261.10 -52.20 652.00 -45.60 151.40 Net Cash Inflow / Outflow 5.70 -1.40 1.00 0.80 -2.80 -3.60 1.40 -2.70 -6.40 92.00 Opening Cash & Equivalents 5.50 6.90 5.90 5.10 7.90 11.50 10.10 12.80 19.20 -170.00 Closing Cash & Equivalent 11.20 5.50 6.90 5.90 5.10 7.90 11.50 10.10 12.80 -76.80

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 1,696.80 1,211.60 849.10 46.50 298.80 417.30 668.80 463.60 345.80 112.20 PBT 2,291.40 1,673.50 861.90 202.20 579.60 568.70 824.70 887.20 624.40 208.60 Adjustment -22.30 133.80 102.00 123.90 62.10 54.00 14.30 75.60 100.20 90.50 Changes in Working Capital -199.70 -309.40 62.70 -231.40 -212.90 -97.60 8.60 -294.60 -253.00 -140.70 Cash after chg. in Working capital 2,069.40 1,497.90 1,026.60 94.70 428.80 525.10 847.60 668.20 471.60 158.40 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -372.60 -286.30 -177.50 -48.20 -130.00 -107.80 -178.80 -204.60 -125.80 -46.20 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -1,414.50 -1,032.70 -477.10 -5.30 -103.30 -167.00 -612.20 -1,115.50 -299.40 -175.50 Net Fixed Assets -515.60 -273.50 -113.40 -204.80 -250.20 -335.80 -436.10 -392.40 -299.40 -303.91 Net Investments -113.40 -84.20 -107.50 -213.00 -145.90 53.30 -94.80 -54.80 -1.00 37.47 Others -785.50 -675.00 -256.20 412.50 292.80 115.50 -81.30 -668.30 1.00 90.94 Cash from Financing Activity -210.70 -246.90 -363.00 34.80 -185.70 -250.80 -50.90 650.90 -47.70 154.00 Net Cash Inflow / Outflow 71.60 -68.00 9.00 76.00 9.80 -0.50 5.70 -1.00 -1.30 90.70 Opening Cash & Equivalents 70.40 131.90 111.10 25.80 19.80 28.30 21.70 23.50 24.20 -164.10 Closing Cash & Equivalent 120.00 70.40 131.90 111.10 25.80 19.80 28.30 21.70 23.50 -74.20

Financial Ratios

Consolidated /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 409.72 312.42 257.64 229.51 223.21 211.31 193.55 168.09 96.52 76.24 ROA 25.05% 21.90% 12.29% 2.86% 6.59% 10.54% 16.49% 22.95% 23.62% 10.90% ROE 28.63% 25.38% 14.33% 3.37% 7.82% 12.86% 20.11% 29.18% 32.87% 16.00% ROCE 33.11% 29.02% 16.51% 3.79% 9.46% 14.85% 23.91% 34.58% 38.71% 18.48% Fixed Asset Turnover 1.19 1.15 0.78 0.65 0.70 0.99 1.41 1.65 1.88 1.20 Receivable days 97.17 90.80 104.18 96.61 101.41 99.38 92.04 93.04 66.04 76.63 Inventory Days 53.39 58.90 100.00 145.29 140.07 99.81 78.34 66.02 62.77 94.81 Payable days 136.76 126.93 121.62 102.03 144.40 66.65 73.69 81.82 79.78 95.04 Cash Conversion Cycle 13.80 22.77 82.56 139.87 97.08 132.54 96.69 77.23 49.02 76.39 Total Debt/Equity 0.04 0.06 0.03 0.09 0.06 0.08 0.11 0.06 0.13 0.08 Interest Cover 114.57 108.26 90.62 12.72 35.71 29.31 46.07 61.38 37.23 11.11

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 424.97 326.99 267.06 233.44 224.88 206.04 189.49 165.22 93.63 73.91 ROA 24.35% 22.13% 13.29% 3.43% 9.43% 10.30% 16.02% 23.05% 23.43% 9.72% ROE 27.98% 25.88% 15.66% 4.06% 11.27% 12.71% 19.75% 29.70% 33.21% 14.62% ROCE 32.85% 30.08% 18.06% 4.86% 13.99% 14.82% 23.71% 35.28% 39.21% 18.04% Fixed Asset Turnover 1.25 1.24 0.89 0.76 0.86 1.07 1.47 1.72 1.93 1.23 Receivable days 93.30 86.16 93.53 85.10 84.44 93.77 91.36 92.22 65.12 70.27 Inventory Days 56.17 60.81 95.32 128.47 118.77 96.38 77.28 65.25 62.41 89.35 Payable days 145.20 136.43 133.18 106.38 151.52 65.96 72.53 81.42 78.30 85.42 Cash Conversion Cycle 4.27 10.54 55.67 107.20 51.68 124.19 96.11 76.05 49.23 74.21 Total Debt/Equity 0.04 0.06 0.03 0.09 0.06 0.08 0.11 0.06 0.14 0.09 Interest Cover 96.87 88.16 60.44 12.42 44.58 27.45 43.73 58.61 34.75 10.11

Top Investors:

belgrave investment fund

life insurance corporation of india

tata mutual fund- tata value fund

akash bhanshali

investor education and protection fund (iepf)

llp

Annual Reports:

News Update:

Natco Pharma gets CDSCO’s approval for Semaglutide Injection in India
14th Feb 2026, 11:12 AM

NATCO will launch the product in the India market in March 2026
Read More
Natco Pharma gets EIR for API division in Chennai
13th Feb 2026, 10:21 AM

The said facility has received Voluntary Action Indicated (VAI) classification
Read More
Natco Pharma - Quarterly Results
13th Feb 2026, 00:00 AM

Read More
Natco Pharma gets nod to incorporate wholly owned subsidiary in Chile
12th Feb 2026, 16:44 PM

The Board of Directors of the company at their meeting held on February 12, 2026 has approved the same
Read More
Natco Pharma reports 14% rise in Q3 consolidated net profit
12th Feb 2026, 16:00 PM

The consolidated total income of the company increased by 8.34% at Rs 705.40 crore for Q3FY26
Read More
NATCO Pharma gets USFDA's tentative approval for Erdafitinib Tablets
3rd Feb 2026, 15:17 PM

Erdafitinib tablets had estimated sales of around $60 million in the U.S. for 12 months ending September 2025 as per industry sales data
Read More
Natco Pharma’s arm acquires 49% stake in PT NATCO Lotus Farma
30th Jan 2026, 14:59 PM

Post this acquisition, the company along with its WOS wholly-owns 100% of PT NATCO Lotus Farma
Read More
USFDA concludes inspection at Natco Pharma’s API manufacturing plant in Manali
21st Nov 2025, 17:24 PM

The said inspection was conducted from November 17, 2025 to November 21, 2025
Read More

Natco Pharma Ltd.

Pharmaceuticals & Drugs - Global

BSE: 524816 | NSE: NATCOPHARM

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Natco Pharma Ltd.

Pharmaceuticals & Drugs - Global

BSE: 524816 | NSE: NATCOPHARM

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: